Latest filings (excl ownership)
15-12G
Securities registration termination
23 Aug 17
8-K
Financial Statements and Exhibits
22 Feb 17
PRER14C
Preliminary revised information
22 Feb 17
PRE 14C
Preliminary information
20 Jan 17
8-K
Entry into a Material Definitive Agreement
30 Dec 16
8-K
Series B Convertible Preferred Stock Purchase Agreement
2 Dec 16
8-K
Entry into a Material Definitive Agreement
15 Nov 16
8-K
Entry into a Material Definitive Agreement
26 Oct 16
8-K
Entry into a Material Definitive Agreement
24 Jun 16
NT 10-K
Notice of late annual filing
1 Dec 15
10-Q
2015 Q3
Quarterly report
20 Jul 15
NT 10-Q
Notice of late quarterly filing
15 Jul 15
10-Q
2015 Q2
Quarterly report
14 Apr 15
10-Q
2015 Q1
Quarterly report
16 Jan 15
NT 10-Q
Notice of late quarterly filing
14 Jan 15
8-K/A
Financial Statements and Exhibits
13 Jan 15
10-K/A
2014 FY
Annual report (amended)
15 Dec 14
10-K
2014 FY
Annual report
11 Dec 14
NT 10-K
Notice of late annual filing
1 Dec 14
8-K
Entry into a Material Definitive Agreement
2 Oct 14
10-K/A
2013 FY
Annual report (amended)
30 Sep 14
10-K/A
2013 FY
Annual report (amended)
31 Jul 14
8-K
Departure of Directors or Certain Officers
22 Jul 14
10-Q
2014 Q3
Quarterly report
15 Jul 14
8-K
Unregistered Sales of Equity Securities
28 May 14
10-Q
2014 Q2
Quarterly report
21 Apr 14
NT 10-Q
Notice of late quarterly filing
14 Apr 14
DEF 14C
Information statement
7 Feb 14
PRE 14C
Preliminary information
28 Jan 14
10-Q
2014 Q1
Quarterly report
16 Jan 14
NT 10-Q
Notice of late quarterly filing
14 Jan 14
8-K
Oncologix Closes $4,000,000 Revolving Line Credit Facility from Senior Lender
8 Jan 14
8-K/A
Financial Statements and Exhibits
8 Jan 14
8-K/A
Financial Statements and Exhibits
8 Jan 14